Whole Exome Sequencing Identifies Novel Recurrently Mutated Genes in Patients with Splenic Marginal Zone Lymphoma-Reference-Cited by-同舟云学术

Whole Exome Sequencing Identifies Novel Recurrently Mutated Genes in Patients with Splenic Marginal Zone Lymphoma

Published:2013-12-13 Issue:12 Volume:8 Page:e83244
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Parry Marina,Rose-Zerilli Matthew J. J.,Gibson Jane,Ennis Sarah,Walewska Renata,Forster Jade,Parker Helen,Davis Zadie,Gardiner Anne,Collins Andrew,Oscier David G.,Strefford Jonathan C.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria;E Matutes;Leukemia,2008

2. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group;M Salido;Blood,2010

3. An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma;AJ Watkins;PLOS ONE,2012

4. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma;D Rossi;Blood,2011

5. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas;U Novak;Blood,2009

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phospholipase A2 expression in prostate cancer as a biomarker of good prognosis: A comprehensive study in patients with long follow-up;Urologia Journal;2024-07-25

2. The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications;Exploration of Targeted Anti-tumor Therapy;2024-07-23

3. Proliferative History Is a Novel Driver of Clinical Outcome in Splenic Marginal Zone Lymphoma;2024-01-17

4. The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop;Virchows Archiv;2023-09

5. Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy;BMC Cancer;2023-08-24